N. Roger et al., EFFECT OF NITRIC-OXIDE INHALATION ON RESPIRATORY SYSTEM RESISTANCE INCHRONIC OBSTRUCTIVE PULMONARY-DISEASE, The European respiratory journal, 9(2), 1996, pp. 190-195
Nitric oxide (NO) has been identified as a neurotransmitter of nonadre
nergic noncholinergic bronchodilator nerves. To investigate whether in
haled NO exerts a bronchodilator effect in patients with chronic obstr
uctive pulmonary disease (COPD), we measured the resistance of the res
piratory system, using the forced oscillation technique, while breathi
ng NO. Eight patients with COED (7 men and 1 woman; aged 66+/-7 yrs (m
ean+/-SD); forced expiratory volume in one second (FEV1) 37+/-17% of p
redicted) and eight healthy subjects (7 men and 1 woman; 33+/-4 yrs; F
EV1 108+/-14% pred) were studied. Nitric oxide, at a concentration of
40 parts per million (ppm) in air, was inhaled for 20 min. Total resis
tance (Rrs) and reactance (Xrs) of the respiratory system, arterial ox
ygen saturation, heart rate, tidal volume, and breathing frequency wer
e continuously recorded at baseline, and during and after ceasing NO i
nhalation. Methaemoglobin levels were additionally measured in healthy
subjects. At baseline, patients with COPD showed higher Rrs than heal
thy subjects (Rrs at 10 Hz (Rrs,lo) 4.97+/-2.19 vs 2.29+/-0.65 hPa . L
(-1). s). During NO inhalation, no significant change in Rrs or in Xrs
was observed. Mean variation in Rrs,10 while breathing NO was negligi
ble and similar in the two groups (-0.10+/-0.13 hPa . L(-1). s in COPD
patients and -0.02+/-0.13 hPa . L(-1). s in healthy subjects), Moreov
er, there were no differences in oxygen saturation, heart rate, tidal
volume and breathing frequency during NO inhalation, Methaemoglobinaem
ia increased at the end of NO inhalation (from 0.48+/-0.18 to 0.81+/-0
.16%), and this increment remained 10 min later (0.86+/-0.31%). From t
hese results, we conclude that inhaled nitric oxide, at a concentratio
n of 40 ppm, exerts no effect on respiratory system resistance in pati
ents with chronic obstructive pulmonary disease or in healthy subjects
.